Lydia Aschauer

962 total citations
17 papers, 568 citations indexed

About

Lydia Aschauer is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lydia Aschauer has authored 17 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Lydia Aschauer's work include Carcinogens and Genotoxicity Assessment (5 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Lydia Aschauer is often cited by papers focused on Carcinogens and Genotoxicity Assessment (5 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Lydia Aschauer collaborates with scholars based in Austria, United Kingdom and Germany. Lydia Aschauer's co-authors include Paul Jennings, Alice Limonciel, Anja Wilmes, Patricia Müller, Martin O. Leonard, Walter Pfaller, Philip Hewitt, Giada Carta, Eberhard Schlatter and Arno Lukas and has published in prestigious journals such as Molecular and Cellular Biology, Toxicology and Applied Pharmacology and Cell Death and Disease.

In The Last Decade

Lydia Aschauer

17 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lydia Aschauer Austria 13 321 118 89 88 74 17 568
P. E. Noker United States 11 188 0.6× 41 0.3× 41 0.5× 24 0.3× 50 0.7× 20 461
Baoxia He China 15 349 1.1× 86 0.7× 147 1.7× 19 0.2× 22 0.3× 30 623
Patrik Strömberg Sweden 13 185 0.6× 36 0.3× 34 0.4× 20 0.2× 115 1.6× 20 456
Lisa Fredriksson Netherlands 8 151 0.5× 59 0.5× 56 0.6× 37 0.4× 62 0.8× 10 395
Andrew R. Kraynak United States 13 365 1.1× 115 1.0× 348 3.9× 22 0.3× 16 0.2× 19 716
Bridgett Green United States 12 492 1.5× 119 1.0× 229 2.6× 75 0.9× 31 0.4× 13 881
Adriaan Brouwer Netherlands 18 354 1.1× 123 1.0× 53 0.6× 18 0.2× 52 0.7× 26 862
Thomas C. Dembinski Canada 12 326 1.0× 146 1.2× 67 0.8× 34 0.4× 21 0.3× 27 695
Philip Klubes United States 16 252 0.8× 237 2.0× 78 0.9× 27 0.3× 30 0.4× 32 551
Guanghui Ren China 10 251 0.8× 62 0.5× 64 0.7× 12 0.1× 25 0.3× 21 395

Countries citing papers authored by Lydia Aschauer

Since Specialization
Citations

This map shows the geographic impact of Lydia Aschauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Aschauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Aschauer more than expected).

Fields of papers citing papers by Lydia Aschauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lydia Aschauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Aschauer. The network helps show where Lydia Aschauer may publish in the future.

Co-authorship network of co-authors of Lydia Aschauer

This figure shows the co-authorship network connecting the top 25 collaborators of Lydia Aschauer. A scholar is included among the top collaborators of Lydia Aschauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lydia Aschauer. Lydia Aschauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Aschauer, Lydia, et al.. (2021). Rab11-FIP1/RCP Functions as a Major Signalling Hub in the Oncogenic Roles of Mutant p53 in Cancer. Frontiers in Oncology. 11. 804107–804107. 2 indexed citations
2.
Officer-Jones, Leah, Lydia Aschauer, Sara Zanivan, et al.. (2021). Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane. Cell Death and Disease. 12(2). 207–207. 16 indexed citations
3.
Limonciel, Alice, Simone G. van Breda, Xiaoqi Jiang, et al.. (2018). Persistence of Epigenomic Effects After Recovery From Repeated Treatment With Two Nephrocarcinogens. Frontiers in Genetics. 9. 558–558. 4 indexed citations
4.
Aschauer, Lydia & Patricia Müller. (2016). Novel targets and interaction partners of mutant p53 Gain-Of-Function. Biochemical Society Transactions. 44(2). 460–466. 58 indexed citations
5.
Limonciel, Alice, S Stanzel, C. Parmentier, et al.. (2015). Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing. Toxicology in Vitro. 30(1). 7–18. 21 indexed citations
6.
Bloch, Katarzyna, Andrew R. Evans, Lydia Aschauer, et al.. (2015). Transcriptomic alterations induced by Monuron in rat and human renal proximal tubule cells in vitro and comparison to rat renal-cortex in vivo. Toxicology Research. 4(2). 423–431. 4 indexed citations
7.
Jennings, Paul, Daniel Crean, Lydia Aschauer, et al.. (2014). Interleukin-19 as a translational indicator of renal injury. Archives of Toxicology. 89(1). 101–106. 22 indexed citations
8.
Crean, Daniel, Patricia Bellwon, Lydia Aschauer, et al.. (2014). Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testing. Toxicology in Vitro. 30(1). 128–137. 33 indexed citations
9.
Wilmes, Anja, Lydia Aschauer, Alice Limonciel, Walter Pfaller, & Paul Jennings. (2014). Evidence for a role of claudin 2 as a proximal tubular stress responsive paracellular water channel. Toxicology and Applied Pharmacology. 279(2). 163–172. 30 indexed citations
10.
Wilmes, Anja, Chris Bielow, Patricia Bellwon, et al.. (2014). Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. Toxicology in Vitro. 30(1). 117–127. 98 indexed citations
11.
Aschauer, Lydia, et al.. (2014). Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC/TERT1. Toxicology in Vitro. 30(1). 95–105. 55 indexed citations
12.
Aschauer, Lydia, Alice Limonciel, Anja Wilmes, et al.. (2014). Application of RPTEC/TERT1 cells for investigation of repeat dose nephrotoxicity: A transcriptomic study. Toxicology in Vitro. 30(1). 106–116. 46 indexed citations
13.
Aschauer, Lydia, Anja Wilmes, Alice Limonciel, et al.. (2014). Application of a human renal proximal tubule cell line, RPTEC/TERT1, for chemical safety assessment. Toxicology Letters. 229. S242–S243. 1 indexed citations
14.
Aschauer, Lydia, Leonhard Gruber, Walter Pfaller, et al.. (2013). Delineation of the Key Aspects in the Regulation of Epithelial Monolayer Formation. Molecular and Cellular Biology. 33(13). 2535–2550. 59 indexed citations
15.
Limonciel, Alice, Anja Wilmes, Lydia Aschauer, et al.. (2012). Oxidative stress induced by potassium bromate exposure results in altered tight junction protein expression in renal proximal tubule cells. Archives of Toxicology. 86(11). 1741–1751. 30 indexed citations
16.
Limonciel, Alice, Lydia Aschauer, Anja Wilmes, et al.. (2011). Lactate is an ideal non-invasive marker for evaluating temporal alterations in cell stress and toxicity in repeat dose testing regimes. Toxicology in Vitro. 25(8). 1855–1862. 55 indexed citations
17.
Jennings, Paul, Alice Limonciel, Katarzyna Bloch, et al.. (2011). Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model. Archives of Toxicology. 86(4). 571–589. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026